TSHA logo

Taysha Gene Therapies (TSHA)

Profile

Full Name

Taysha Gene Therapies, Inc.

Ticker Symbol

TSHA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 24, 2020

Indexes

Not included

Website

http://www.tayshagtx.com

Employees

73

Key Details

Price

$2.38(-1.24%)

Market cap

$510.89M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.33M(-46.07% YoY)

Annual EPS

-$0.36(+62.50% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.38
    TSHA price is $2.38

    30-Day Relative Volume

    0.49
    TSHA 30-day relative volume is 0.49

    Price Performance

    Price Most recent change

    -1.24%
    TSHA price was down -1.24% on Jun 27, 2025

    Price YTD change

    +37.57%
    TSHA price is up +37.57% since January 1st

    Price 1-year change

    +9.93%
    TSHA price is up +9.93% year-on-year

    Price 3-year change

    -40.5%
    TSHA price is down -40.5% over the past 3 years

    Price Range

    Price All-time high

    $33.35
    TSHA price is currently -92.86% below its historical high of $33.35

    Price 3-year low

    $0.50
    TSHA price is currently +376.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $510.89M
    TSHA market capitalization is $510.89 million

    Market cap 3-year change

    +215.01%
    TSHA market capitalization is up +215.01% over the past 3 years

    Market cap All-time high

    $1.20B
    TSHA market capitalization is currently -57.39% below its historical high of $1.20 billion

    Market cap sector rank

    68%
    TSHA market capitalization is higher than 68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +6.6%
    TSHA shares outstanding is up +6.6% year-on-year

    Shares Outstanding 3-Year Change

    +429.42%
    TSHA shares outstanding is up +429.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.18
    TSHA beta is 1.18

    200-day SMA

    $1.99
    TSHA price is currently +19.69% above its 200-day simple moving average

    50-day SMA

    $2.38
    TSHA price is currently +0.19% above its 50-day simple moving average

    RSI

    43.46
    TSHA 14-day relative strength index is 43.46

    Volume

    0.49
    TSHA 30-day relative volume is 0.49

    ATR

    $0.18
    TSHA average true range is $0.18

    10-day Historical Volatility

    41.88%
    TSHA 10-day historical volatility is 41.88%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $8.33M
    TSHA annual revenue is $8.33 million

    Revenue Analysts estimate

    $7.14M
    TSHA annual revenue is currently +16.63% higher than the consensus analysts' forecast

    Revenue 1-year change

    -46.07%
    TSHA annual revenue is down -46.07% year-on-year

    Revenue Sector rank

    25%
    TSHA annual revenue is higher than 25% of companies in Healthcare sector

    EPS

    EPS

    -$0.36
    TSHA annual earnings per share is -$0.36

    EPS Analysts estimate

    -$0.29
    TSHA annual earnings per share is currently +25.22% higher than the consensus analysts' forecast

    EPS 1-year change

    +62.5%
    TSHA annual earnings per share is up +62.5% year-on-year

    EPS Sector rank

    71.52%
    TSHA annual earnings per share is higher than 71.52% of companies in Healthcare sector

    Profit

    Gross profit

    -
    TSHA annual gross profit value is unknown

    Gross margin

    -
    TSHA annual gross profit margin value is unknown

    Operating profit

    -$86.62M
    TSHA annual operating income is -$86.62 million

    Operating margin

    -1039.49%
    TSHA annual operating profit margin is -1039.49%

    Net income

    -$89.30M
    TSHA annual net profit is -$89.30 million

    Net margin

    -1071.62%
    TSHA annual net profit margin is -1071.62%

    Expenses

    Total expenses

    $94.95M
    TSHA annual total expenses is $94.95 million

    Operating expenses

    $94.95M
    TSHA annual total operating expenses is $94.95 million

    Cost of goods sold

    -
    TSHA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $28.95M
    TSHA annual SGA is $28.95 million

    Depreciation and amortization

    $1.25M
    TSHA annual depreciation & amortization is $1.25 million

    Interest expense

    $102.00K
    TSHA annual interest expense is $102.00 thousand

    Income tax

    -
    TSHA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$89.20M
    TSHA annual earnings before interest & taxes is -$89.20 million

    EBITDA

    -$87.95M
    TSHA annual EBITDA is -$87.95 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $160.36M
    TSHA annual total assets is $160.36 million

    Non current assets

    $18.23M
    TSHA annual long term assets is $18.23 million

    Current assets

    $142.13M
    TSHA annual total current assets is $142.13 million

    Cash and cash equivalents

    $139.04M
    TSHA annual cash & cash equivalents is $139.04 million

    Accounts receivable

    -
    TSHA annual accounts receivable value is unknown

    Inventory

    -
    TSHA annual inventory value is unknown

    Liabilities

    Total liabilities

    $88.84M
    TSHA annual total liabilities is $88.84 million

    Long term liabilities

    $62.61M
    TSHA annual total long term liabilities is $62.61 million

    Current liabilities

    $26.23M
    TSHA annual total current liabilities is $26.23 million

    Accounts payable

    $3.59M
    TSHA annual accounts payable is $3.59 million

    Debt

    Total debt

    $63.18M
    TSHA annual total debt is $63.18 million

    Total debt 1-year change

    +3.39%
    TSHA annual total debt is up +3.39% year-on-year

    Long term debt

    $61.30M
    TSHA annual long term debt is $61.30 million

    Short term debt

    $1.88M
    TSHA annual short term debt is $1.88 million

    Equity & Capital

    Shareholders equity

    $71.53M
    TSHA annual stockholders equity is $71.53 million

    Book value

    $71.53M
    TSHA annual book value is $71.53 million

    Retained earnings

    -$602.30M
    TSHA annual retained earnings is -$602.30 million

    Working capital

    $115.90M
    TSHA annual working capital is $115.90 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$81.22M
    TSHA annual cash flow from operations is -$81.22 million

    Cash from operations 1-year change

    -11.24%
    TSHA annual cash flow from operations is down -11.24% year-on-year

    Cash from investing

    -$363.00K
    TSHA annual cash flow from investing activities is -$363.00 thousand

    Cash from investing 1-year change

    +95.06%
    TSHA annual cash flow from investing activities is up +95.06% year-on-year

    Cash from financing

    $76.68M
    TSHA annual cash flow from financing activities is $76.68 million

    Cash from financing 1-year change

    -43.78%
    TSHA annual cash flow from financing activities is down -43.78% year-on-year

    CAPEX

    CAPEX

    $374.00K
    TSHA annual capital expenditures is $374.00 thousand

    CAPEX 1-year change

    -94.92%
    TSHA annual capital expenditures is down -94.92% year-on-year

    Free Cash Flow

    Free cash flow

    -$81.60M
    TSHA annual free cash flow is -$81.60 million

    Free cash flow 1-year change

    -1.51%
    TSHA annual free cash flow is down -1.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TSHA annual gross profit margin value is unknown

    Operating margin

    -1039.49%
    TSHA annual operating profit margin is -1039.49%

    Net margin

    -1071.62%
    TSHA annual net profit margin is -1071.62%

    ROA & ROE

    ROA

    -53.62%
    TSHA annual return on assets is -53.62%

    ROE

    -121.94%
    TSHA annual return on equity is -121.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TSHA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TSHA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    9.28
    TSHA price to book ratio is 9.28

    PB ratio Sector rank

    89.68%
    TSHA price to book ratio is higher than 89.68% of companies in Healthcare sector

    PS Ratio

    PS ratio

    70.72
    TSHA price to sales ratio is 70.72

    PS ratio Sector rank

    93.51%
    TSHA price to sales ratio is higher than 93.51% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $455.66M
    TSHA enterprise value is $455.66 million

    Enterprise value Sector rank

    65.79%
    TSHA enterprise value is higher than 65.79% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.33
    TSHA EV/EBITDA is -5.33

    EV/EBITDA Sector rank

    21.76%
    TSHA EV/EBITDA is higher than 21.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.42
    TSHA annual current ratio is 5.42

    Quick ratio

    -
    TSHA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.61
    TSHA annual debt to equity ratio is 0.61

    Interest coverage ratio

    -874.47
    TSHA annual interest coverage ratio is -874.47

    Risk & Stability

    Piotroski F-Score

    -
    TSHA piotroski f-score value is unknown

    Altman Z-Score

    -2.72
    TSHA altman z-score is -2.72

    Analyst ratings

    Recent major analysts updates

    Jun 10, 25 Needham
    Buy
    Jun 3, 25 Canaccord Genuity
    Buy
    Jun 2, 25 Needham
    Buy
    May 29, 25 JMP Securities
    Market Outperform
    May 29, 25 Chardan Capital
    Buy
    May 16, 25 Canaccord Genuity
    Buy
    Apr 28, 25 JMP Securities
    Market Outperform
    Apr 28, 25 Cantor Fitzgerald
    Overweight
    Apr 10, 25 Needham
    Buy
    Feb 27, 25 Needham
    Buy

    Institutional Ownership

    Screeners with TSHA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Taysha Gene Therapies?
    • Does Taysha Gene Therapies pay dividends?
    • What sector is Taysha Gene Therapies in?
    • What industry is Taysha Gene Therapies in?
    • What country is Taysha Gene Therapies based in?
    • When did Taysha Gene Therapies go public?
    • Is Taysha Gene Therapies in the S&P 500?
    • Is Taysha Gene Therapies in the NASDAQ 100?
    • Is Taysha Gene Therapies in the Dow Jones?
    • When was Taysha Gene Therapies's last earnings report?
    • When does Taysha Gene Therapies report earnings?
    • Should I buy Taysha Gene Therapies stock now?

    What is the ticker symbol for Taysha Gene Therapies?

    The ticker symbol for Taysha Gene Therapies is NASDAQ:TSHA

    Does Taysha Gene Therapies pay dividends?

    No, Taysha Gene Therapies does not pay dividends

    What sector is Taysha Gene Therapies in?

    Taysha Gene Therapies is in the Healthcare sector

    What industry is Taysha Gene Therapies in?

    Taysha Gene Therapies is in the Biotechnology industry

    What country is Taysha Gene Therapies based in?

    Taysha Gene Therapies is headquartered in United States

    When did Taysha Gene Therapies go public?

    Taysha Gene Therapies's initial public offering (IPO) was on September 24, 2020

    Is Taysha Gene Therapies in the S&P 500?

    No, Taysha Gene Therapies is not included in the S&P 500 index

    Is Taysha Gene Therapies in the NASDAQ 100?

    No, Taysha Gene Therapies is not included in the NASDAQ 100 index

    Is Taysha Gene Therapies in the Dow Jones?

    No, Taysha Gene Therapies is not included in the Dow Jones index

    When was Taysha Gene Therapies's last earnings report?

    Taysha Gene Therapies's most recent earnings report was on May 15, 2025

    When does Taysha Gene Therapies report earnings?

    The next expected earnings date for Taysha Gene Therapies is Aug 12, 2025

    Should I buy Taysha Gene Therapies stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page